Health and Healthcare

Amgen : AMGN

All Amgen Articles

704 Articles

Trey Thoelcke | Feb 27, 2014 at 7:00 AM EST

Short Sellers Return to Biotech Stocks

After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical…

Trey Thoelcke | Feb 12, 2014 at 6:50 AM EST

Short Sellers Shy Away From Biotechs

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers…

Paul Ausick | Feb 5, 2014 at 8:20 AM EST

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to…

cgblaine22 | Jan 29, 2014 at 12:10 PM EST

Why Caution Is Prevailing in Biotechs Into and After Earnings

Biogen Idec surprised investors Wednesday with weaker-than-expected guidance for 2014 earnings. Amgen beat estimates late Tuesday. Celgene and Gilead Sciences…

Trey Thoelcke | Jan 29, 2014 at 8:15 AM EST

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large…

Jon C. Ogg | Jan 28, 2014 at 4:13 PM EST

Amgen Nails Earnings, Guidance a Different Story

ThinkstockAmgen Inc. (NASDAQ: AMGN) is the second largest biotech player, and now we have seen its fourth-quarter earnings report. Earnings…

Trey Thoelcke | Jan 22, 2014 at 9:05 AM EST

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we…

Trey Thoelcke | Dec 19, 2013 at 8:30 AM EST

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.

Jon C. Ogg | Nov 21, 2013 at 7:55 AM EST

Eight Big Dividend Hikes Expected Before 2013 Ends

ThinkstockInvestors love dividends, particularly safe and dependable dividends that rise through time. The S&P 500 Index currently has the most…

Jon C. Ogg | Nov 19, 2013 at 11:50 AM EST

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies…

Lee Jackson | Nov 14, 2013 at 9:30 AM EST

Five Prime Takeover Candidates for 2014

ThinkstockMany Wall Street analysts and strategists are forecasting a rise in corporate earnings for the rest of the year and…

Lee Jackson | Nov 6, 2013 at 8:30 AM EST

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

ThinkstockThe UBS proprietary institutional flow data indicates that hedge funds are increasing exposure to financials and decreasing exposure to health…

Jon C. Ogg | Oct 21, 2013 at 11:10 AM EDT

The Top 14 Earnings to Watch This Week

Jon OggThe S&P 500 Index is hitting all-time highs and we are now deep into earnings season. This week will…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Jon C. Ogg | Oct 8, 2013 at 2:47 PM EDT

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such,…

1 … 30 31 32 33 34 … 47

Amgen : AMGN

All Amgen Articles

Short Sellers Return to Biotech Stocks

Short Sellers Shy Away From Biotechs

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Why Caution Is Prevailing in Biotechs Into and After Earnings

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Amgen Nails Earnings, Guidance a Different Story

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

Eight Big Dividend Hikes Expected Before 2013 Ends

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Five Prime Takeover Candidates for 2014

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

The Top 14 Earnings to Watch This Week

Jefferies Top Biotech Stocks to Buy

Market Take: Biotech Suffers Under Government Shutdown Too!

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here’s How to Claim 30% Back

Ethereum Rallied 8% This Month While XRP Fell. Which Is the Better Buy?

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here's How to Claim 30% Back

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here’s How to Claim 30% Back

Amgen : AMGN

All Amgen Articles

Short Sellers Return to Biotech Stocks

Short Sellers Shy Away From Biotechs

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Why Caution Is Prevailing in Biotechs Into and After Earnings

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Amgen Nails Earnings, Guidance a Different Story

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

Eight Big Dividend Hikes Expected Before 2013 Ends

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Five Prime Takeover Candidates for 2014

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

The Top 14 Earnings to Watch This Week

Jefferies Top Biotech Stocks to Buy

Market Take: Biotech Suffers Under Government Shutdown Too!

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here’s How to Claim 30% Back

Ethereum Rallied 8% This Month While XRP Fell. Which Is the Better Buy?

Featured Reads

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here's How to Claim 30% Back